INSMED INC Property, Plant and Equipment, Gross
INSMED INC (INSM) had Property, Plant and Equipment, Gross of $173.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $173.91M.
- 2026-03-31: Property, Plant and Equipment, Gross $166.44M.
- 2025-12-31: Property, Plant and Equipment, Gross $163.70M.
- 2025-09-30: Property, Plant and Equipment, Gross $146.87M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $173.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $166.44M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $163.70M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $146.87M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $144.79M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $140.60M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $130.36M 10-K · filed 2026-02-19 |
| 2024-09-30 | $124.20M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $120.12M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $114.63M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $110.01M 10-K · filed 2025-02-20 |
| 2023-09-30 | $107.76M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $104.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $100.23M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $95.94M 10-K · filed 2024-02-22 |
| 2022-09-30 | $91.71M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $93.25M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $91.02M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $90.02M 10-K · filed 2023-02-23 |
| 2021-09-30 | $88.56M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $86.91M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $83.42M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $82.30M 10-K · filed 2022-02-17 |
| 2020-09-30 | $81.35M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $80.57M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $80.12M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $79.45M 10-K · filed 2021-02-25 |
| 2019-09-30 | $70.51M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $55.33M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $36.81M 10-K · filed 2020-02-25 |
| 2017-12-31 | $23.08M 10-K · filed 2019-02-22 |
| 2016-12-31 | $17.76M 10-K · filed 2018-02-23 |
| 2015-12-31 | $13.40M 10-K · filed 2017-02-23 |
| 2014-12-31 | $10.86M 10-K · filed 2016-02-25 |
| 2013-12-31 | $5.37M 10-K · filed 2015-02-27 |
| 2012-12-31 | $4.55M 10-K · filed 2014-03-06 |
| 2011-12-31 | $4.29M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |